Dante Labs
Business Services · Italy · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Strada Statale 17, L'Aquila, Abruzzo, 67...Website
www.dantelabs.comRevenue
$22 MillionIndustry
About Dante Labs
Dante Labs Org Chart
Is Dante Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Dante Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Dante Labs launches new products
Click to see if Dante Labs had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Dante Labs recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Dante Labs has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Dante Labs has new funding data
Check out if Dante Labs is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dante Labs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Dante Labs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dante Labs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dante Labs.
Dante Labs Tech Stack
A closer look at the technologies used by Dante Labs
Most Recent Scoops
Dante Labs News & Media
Dante Labs selected to provide genetic testing for Abu Dhabi Stem Cells Center, jointly developing mRNA cancer vaccines
ADSCC and Dante Labs sign agreement Dr. Yendry Ventura Carmenate, General Manager at Abu Dhabi Stem Cells Center and Carlo Logli, Chief Global Affairs Officer at Dante Labs, signed the agreement at the ADSCC premises in Abu Dhabi. NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic testing provider for Abu Dhabi Stem CellsDante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program, demonstrating the value of the Dante Platform.Dante Labs selected as Genetic Tests provider for Abu Dhabi Executive Office Employee’s Wellbeing Week
Dante Labs meets with Abu Dhabi Executive Office Dante Labs CEO Andrea Riposati and Carlo Logli meet with Dr. Fatima Al Kaabi, Director of Genome Office at Abu Dhabi Executive Office and team. NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce that the company has been selected as a genetic services provider for Abu Dhabi Executive Office (ADEO) employees for theirDante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases
NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced it has partnered with The Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases, oncology and COVID-19. Protelica, the groundbreaking US biotechnology company, has licensed its library of billions of pronectines nanoantibodies and a portfolio of 12 patents to The Renato Dulbecco Foundation. As part of the drug discovery partnership, The Renato D
Top Business Services Companies
Frequently Asked Questions Regarding Dante Labs
Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The company's assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic dat... Read More